The study is a prospective, double blinded, placebo controlled, randomized study to evaluate
the effects of daily oral estrogen supplements on bone health, sexual and reproductive
health, quality of life and markers of inflammation and lung function when given to
hypogonadal women with Cystic Fibrosis related Bone Disease (CFBD).